Tevogen Bio Holdings Inc.(TVGNW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TVGNW Tevogen Bio Holdings Inc.

已收盘 11-22 16:00:00 EST

0.0551

+0.0001

+0.18%

盘后0.0400

-0.0151-27.40%

19:15 EST

最高0.0588	最低0.0450	成交量6.39万
今开0.0505	昨收0.0550	日振幅25.09%
总市值0.00	流通市值0.00	总股本0.00
成交额3,265	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.0551,"timestamp":1732309200000,"preClose":0.055,"halted":0,"volume":63862,"hourTrading":{"tag":"盘后","latestPrice":0.04,"preClose":0.0551,"latestTime":"19:15 EST","volume":5100,"amount":206,"timestamp":1732320956918},"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","marketStatusCode":5,"change":0.0001,"latestTime":"11-22 16:00:00 EST","open":0.0505,"high":0.0588,"low":0.045,"amount":3265.036903,"amplitude":0.250909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"adjPreClose":0.055,"postHourTrading":{"tag":"盘后","latestPrice":0.04,"preClose":0.0551,"latestTime":"19:15 EST","volume":5100,"amount":206,"timestamp":1732320956918},"volumeRatio":1.592148},"requestUrl":"/m/hq/s/TVGNW/tweets","defaultTab":"tweets","newsList":[{"id":"2485303269","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485303269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485303269?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:30","pubTimestamp":1732285851,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时30分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫7.01%。截至发稿，该股报1.53美元/股，成交量16.9181万股，换手率0.10%，振幅1.52%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051a24e1fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051a24e1fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2484954110","title":"Tevogen Bio Holdings Inc.股价上涨21.76% 市值涨6149.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484954110?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113077,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速拉升21.76%。截至发稿，该股报1.66美元/股，成交量1016.98万股，换手率5.96%，振幅1.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311795be4c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2484679388","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679388?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:41","pubTimestamp":1731940870,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时41分，Tevogen Bio Holdings Inc.股票出现异动，股价快速跳水5.21%。截至发稿，该股报1.38美元/股，成交量16.9023万股，换手率0.10%，振幅4.11%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822411098e4341e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2483208804","title":"Tevogen Bio Holdings Inc.盘中异动 急速跳水5.55%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483208804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483208804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:48","pubTimestamp":1731595681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时48分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅下挫5.55%。截至发稿，该股报1.70美元/股，成交量23.611万股，换手率0.14%，振幅7.22%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224801abc163b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224801abc163b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2483882007","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫12.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882007?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:34","pubTimestamp":1731508443,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时34分，Tevogen Bio Holdings Inc.股票出现波动，股价大幅下跌12.92%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322340395be23b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322340395be23b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2481710436","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌6.18%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481710436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481710436?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:37","pubTimestamp":1731076670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时37分，Tevogen Bio Holdings Inc.股票出现波动，股价急速下挫6.18%。截至发稿，该股报1.07美元/股，成交量37.4511万股，换手率0.22%，振幅6.69%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822375098e417ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822375098e417ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2481981287","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.18%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481981287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481981287?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:13","pubTimestamp":1730906003,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时13分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下跌5.18%。截至发稿，该股报1.63美元/股，成交量108.58万股，换手率0.64%，振幅9.30%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231323971a4d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106231323971a4d14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2481500334","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.02%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481500334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481500334?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817073,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分，Tevogen Bio Holdings Inc.股票出现波动，股价急速拉升5.02%。截至发稿，该股报2.06美元/股，成交量59.4504万股，换手率0.35%，振幅5.93%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223113a218c3d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223113a218c3d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2480814575","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480814575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480814575?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730778,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分，Tevogen Bio Holdings Inc.股票出现波动，股价快速下挫5.80%。截至发稿，该股报2.23美元/股，成交量19.646万股，换手率0.12%，振幅3.80%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223258971a4255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223258971a4255&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2480894908","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.53%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480894908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480894908?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:34","pubTimestamp":1730468067,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时34分，Tevogen Bio Holdings Inc.股票出现波动，股价急速下跌5.53%。截至发稿，该股报2.39美元/股，成交量17.6363万股，换手率0.10%，振幅1.98%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121342798e3ffec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121342798e3ffec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2479381740","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.07%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479381740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479381740?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:45","pubTimestamp":1730382357,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时45分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下跌5.07%。截至发稿，该股报2.34美元/股，成交量80.0171万股，换手率0.47%，振幅8.13%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为2.00%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214557ab8b9ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214557ab8b9ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":1},{"id":"2479301785","title":"Tevogen Bio Holdings Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479301785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479301785?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:37","pubTimestamp":1730295444,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时37分，Tevogen Bio Holdings Inc.股票出现波动，股价急速拉升5.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021372498e3f682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021372498e3f682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":1},{"id":"2479283963","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.09%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479283963?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208722,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Tevogen Bio Holdings Inc.股票出现异动，股价大幅上涨5.09%。截至发稿，该股报2.88美元/股，成交量40.0282万股，换手率0.23%，振幅3.28%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921320298e3f17a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921320298e3f17a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":1},{"id":"2478548945","title":"Tevogen Bio Holdings Inc.盘中异动 急速下挫11.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478548945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478548945?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122314,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Tevogen Bio Holdings Inc.股票出现波动，股价快速跳水11.28%。截至发稿，该股报2.71美元/股，成交量125.3万股，换手率0.73%，振幅4.59%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821315495bd751d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821315495bd751d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":1},{"id":"2478936321","title":"Tevogen Bio Holdings Inc.盘中异动 大幅下挫6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478936321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478936321?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863071,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速下挫6.25%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521311195bd58a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521311195bd58a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":1},{"id":"2477337920","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌11.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477337920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477337920?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603885,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速跳水11.67%。截至发稿，该股报1.59美元/股，成交量108.406万股，换手率0.64%，振幅7.22%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131259f56b92d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131259f56b92d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":1},{"id":"2477866239","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨11.05%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866239?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:31","pubTimestamp":1729517496,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价急速拉升11.05%。截至发稿，该股报1.91美元/股，成交量429.33万股，换手率2.52%，振幅1.16%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121313795b8cca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121313795b8cca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":1},{"id":"2476855120","title":"Tevogen Bio Holdings Inc.股价拉升53.85% 市值涨1.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476855120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476855120?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:31","pubTimestamp":1729171885,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时31分，Tevogen Bio Holdings Inc.股票出现波动，股价快速拉升53.85%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172131259f4a85f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172131259f4a85f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":1},{"id":"2475992004","title":"Tevogen Bio Holdings Inc.盘中异动 急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475992004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475992004?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:34","pubTimestamp":1729085677,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时34分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下挫5.05%。截至发稿，该股报1.30美元/股，成交量218.243万股，换手率1.28%，振幅6.56%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621343798e3cc3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621343798e3cc3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":1},{"id":"2474094660","title":"Tevogen Bio Holdings Inc.盘中异动 大幅下跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474094660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474094660?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:31","pubTimestamp":1728653463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时31分，Tevogen Bio Holdings Inc.股票出现异动，股价快速下跌6.34%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Tevogen Bio Holdings Inc.公司简介：Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司，利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法，用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121310395a0740b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121310395a0740b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.0818},{"period":"1month","weight":-0.0803},{"period":"3month","weight":1.5464},{"period":"6month","weight":0.3784},{"period":"1year","weight":0.8966},{"period":"ytd","weight":0.375}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立，后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司，利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞，开发现成的、未经基因改造的精准T细胞疗法，用于治疗传染病、癌症和神经系统疾病，旨在解决大量患者群体的重大未满足需求。","exchange":"NASDAQ","name":"Tevogen Bio Holdings Inc.","nameEN":"Tevogen Bio Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings Inc.(TVGNW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings Inc.(TVGNW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings Inc.,TVGNW,Tevogen Bio Holdings Inc.股票,Tevogen Bio Holdings Inc.股票老虎,Tevogen Bio Holdings Inc.股票老虎国际,Tevogen Bio Holdings Inc.行情,Tevogen Bio Holdings Inc.股票行情,Tevogen Bio Holdings Inc.股价,Tevogen Bio Holdings Inc.股市,Tevogen Bio Holdings Inc.股票价格,Tevogen Bio Holdings Inc.股票交易,Tevogen Bio Holdings Inc.股票购买,Tevogen Bio Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings Inc.(TVGNW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings Inc.(TVGNW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}